Top compounds associated with response to PIR


Feature Type Standardized
Nominal ANOVA
mRNA Irinotecan CCLE pan-cancer AAC -0.19 0.002
mRNA AZD6244 CCLE pan-cancer AAC 0.14 0.005
mRNA PD-0325901 CCLE pan-cancer AAC 0.13 0.007
mRNA AEW541 CCLE pan-cancer AAC 0.14 0.009
mRNA 17-AAG CCLE pan-cancer AAC 0.14 0.01
mRNA Topotecan CCLE pan-cancer AAC -0.11 0.02
mRNA paclitaxel CCLE pan-cancer AAC 0.11 0.03
mRNA PHA-665752 CCLE pan-cancer AAC -0.11 0.04
mRNA TKI258 CCLE pan-cancer AAC 0.1 0.06
mRNA PLX4720 CCLE pan-cancer AAC 0.078 0.1
Download CSV